Company Filing History:
1 out of 106 
1 out of 1 Years Active: 2023
Title: Scott Florentino: Innovator in Sickle Cell Disease Treatment
Introduction
Scott Florentino is a notable inventor based in Locust Valley, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of vaso-occlusive crises associated with sickle cell disease. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Florentino holds a patent for a method that addresses vaso-occlusive crises associated with sickle cell disease. The patent, titled "Method for treating vaso occlusive crises associated with sickle cell disease," involves administering a therapeutically effective amount of 4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate. This invention represents a significant advancement in the treatment options available for patients.
Career Highlights
Throughout his career, Scott Florentino has worked with various companies, including Nicox S.A. and Fera Pharmaceuticals, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Florentino has collaborated with notable professionals in the field, including Brigitte Duquesroix-Chakroun and Frank J Dellafera. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Scott Florentino's work in developing treatments for sickle cell disease showcases his dedication to improving patient outcomes. His patent and collaborations highlight the importance of innovation in the medical field. Florentino's contributions are a testament to the impact that dedicated inventors can have on healthcare.